Clorox Company (The) (NYSE:CLX) Shares Sold by First Quadrant L P CA

First Quadrant L P CA decreased its stake in Clorox Company (The) (NYSE:CLX) by 4.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 216,057 shares of the company’s stock after selling 11,087 shares during the period. First Quadrant L P CA owned about 0.17% of Clorox Company (The) worth $28,787,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of CLX. Korea Investment CORP raised its position in Clorox Company (The) by 938.9% in the first quarter. Korea Investment CORP now owns 178,197 shares of the company’s stock valued at $24,026,000 after buying an additional 161,044 shares during the period. Crossvault Capital Management LLC increased its position in shares of Clorox Company (The) by 3.8% in the first quarter. Crossvault Capital Management LLC now owns 34,684 shares of the company’s stock valued at $4,676,000 after buying an additional 1,285 shares in the last quarter. Park National Corp OH increased its position in shares of Clorox Company (The) by 6.5% in the first quarter. Park National Corp OH now owns 5,440 shares of the company’s stock valued at $733,000 after buying an additional 331 shares in the last quarter. HighPoint Advisor Group LLC increased its position in shares of Clorox Company (The) by 3.0% in the fourth quarter. HighPoint Advisor Group LLC now owns 43,247 shares of the company’s stock valued at $5,509,000 after buying an additional 1,245 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its position in shares of Clorox Company (The) by 2.4% in the first quarter. Ameriprise Financial Inc. now owns 1,076,072 shares of the company’s stock valued at $146,932,000 after buying an additional 25,110 shares in the last quarter. 70.72% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Company (NYSE:CLX) traded down 1.04% during mid-day trading on Friday, hitting $132.77. The stock had a trading volume of 619,717 shares. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The firm’s 50-day moving average is $135.01 and its 200 day moving average is $132.66. The company has a market cap of $17.10 billion, a price-to-earnings ratio of 26.23 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Wednesday, May 3rd. The company reported $1.31 EPS for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.01. Clorox Company (The) had a return on equity of 215.99% and a net margin of 11.22%. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same period last year, the company earned $1.21 earnings per share. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. Equities analysts anticipate that Clorox Company will post $5.31 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, August 4th. Stockholders of record on Wednesday, July 19th will be issued a $0.84 dividend. This is a positive change from Clorox Company (The)’s previous quarterly dividend of $0.80. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.53%. The ex-dividend date is Monday, July 17th. Clorox Company (The)’s dividend payout ratio (DPR) is presently 66.27%.

ILLEGAL ACTIVITY WARNING: “[[title]]” was originally published by [[site]] and is the property of of [[site]]. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at [[permalink]].

CLX has been the subject of several research analyst reports. Zacks Investment Research upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $151.00 target price for the company in a research note on Wednesday, April 5th. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price for the company in a research note on Monday, April 24th. Deutsche Bank AG reiterated a “hold” rating and set a $137.00 target price (up from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. Jefferies Group LLC began coverage on Clorox Company (The) in a research note on Tuesday, April 18th. They set a “hold” rating and a $138.00 target price for the company. Finally, BMO Capital Markets restated a “buy” rating and issued a $136.00 price target on shares of Clorox Company (The) in a research note on Thursday, May 4th. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. Clorox Company (The) has an average rating of “Hold” and an average price target of $128.48.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.